Tim Kutzkey - Profile and Investment Details

Investor Profile

Tim Kutzkey is a Venture Capital, Private Equity Firm, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals, Peloton Therapeutics, Carmot Therapeutics, Kallyope, PTC Therapeutics, Seragon Pharmaceuticals, Immune Design, Sagimet Biosciences, Cyterix Pharmaceuticals, Hexagon Bio, Circle Pharma, Tenaya Therapeutics, IgenicaORIC Pharmaceuticals, Casma Therapeutics, Surrozen, Accent Therapeutics, ProNeurotech, Escient Pharmaceuticals, A2 Biotherapeutics, Effector Therapeutics, Gritstone Oncology, Revolution Medicines, Neurona Therapeutics, Rapt Therapeutics, Arcus Biosciences, Plexium, Synthekine, Nurix Therapeutics, Ribon Therapeutics, Flexus Biosciences, Aragon Pharmaceuticals, . Over time, Tim Kutzkey has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Tim Kutzkey is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Portfolio Management, Education, Finance, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Digital Health, Medical, Big Data, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Tim Kutzkey, as their portfolio suggests a familiarity and interest in this area.

Understanding Tim Kutzkey’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.